2019 World Molecular Imaging Conference Poster

This study is the Company's first reported results demonstrating that the anti-HER2 nanoparticles used in Imagion's Magsense™ technology, which provide…


Tumor Detection Study Presented at "Frontiers in Biomagnetic Particles" Conference

On June 5, 2017, Imagion Biosystems Chief Scientist Erika Vreeland, PhD, presented the results of a collaborative tumor detection study to the scientific…


HER-2 Positive Tumor Detection at Tech Connect World Innovation Conference

This year's Tech Connect World Innovation Conference featured the poster "Superparamagnetic relaxometry (SPMR) for sensitive detection of HER-2 positive tumors…


Improving Detection Sensitivity

Scientists at Imagion Biosystems, along with our collaborators, continue to push back the boundaries of detection limits in our quest to improve on the early…


Detecting Small Tumors

Cancerous tumors start small and grow larger over time, adding defensive mechanisms that make them resistant to treatments and more deadly. So, to find cancers…